The Actuaries Redraw the Tables, Quietly, for Everyone

GENEVA — There was no announcement, no hearing, no rally — only a revised mortality table circulated among underwriters this autumn, and in its columns a change that touches everyone alive. As augmentation stretches healthy life past a hundred and twenty for those who can afford it, the actuaries who price the risk of living have been forced to split their tables in two: one curve for the enhanced, another for the roughly ninety-five-year baseline that remains the human default. The consequence, spreading quietly through pension and insurance markets, is that the unenhanced are increasingly priced against a longevity they were never offered. "The enhanced pay more per year and get far more years; the baseline majority subsidizes a future it can't buy," said Dr. Naomi Eze, who studies the equity of the split. Somaform Augmetics and its rivals sell the longevity; the actuaries merely count it. No legislature debated the tables, no minister signed them. Yet they may reshape more lives than any vote this season, and almost no one outside Geneva's underwriting floors knows they changed at all.